Company intelligence / Profile preview

HeartForce Medical

Vancouver, British Columbia, Canadaheartforce.com ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

HeartForce Medical has developed and commercialized non-invasive, AI-powered heart assessment devices for early detection of coronary artery disease. Their core technology uses seismocardiography and gyrocardiography to capture heart vibration waveforms, which are analyzed with a deep learning model to provide real-time CAD risk scores. The device is FDA-cleared and CE-marked, with clinical studies supporting its accuracy over traditional screening methods.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapyAI-based diagnostic tool (deep learning model)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on HeartForce Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HeartForce Medical.

Explore the full profile